Else Nutrition Holdings Inc.
Other OTCCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- CEO
- Hamutal Yitzhak
- Full Time Employees
- 32
- Sector
- Consumer Defensive
- Industry
- Packaged Foods
- Address
- 4 Raul Wallenberg Street Tel Aviv Israel 6971904
- IPO Date
- Sep 26, 2019
- Website
- elsenutrition.com
- Similar Companies
- Business
- Else Nutrition Holdings Inc. Else Nutrition Holdings Inc. is a Canada-based food and nutrition company focused on the research, development, manufacturing, marketing, sale, and licensing of innovative, clean, plant-based nutrition products for infants, toddlers, children, and adults. The company offers a portfolio of dairy-free, soy-free, gluten-free products including plant-based complete nutrition shakes for toddlers made from whole foods such as organic almonds, buckwheat, and tapioca; baby cereals; kids shakes; and non-soy formulas as alternatives to traditional dairy-based infant formulas, all featuring minimally processed wholefood ingredients like sustainably sourced buckwheat from Germany, tapioca for easy digestion, and added vitamins including A, iron, B2, B12, and calcium to support growth, immune health, brain development, and sensitive tummies. Founded in 2011 and headquartered in Tel Aviv, Israel, with operations in North America including Canada and the United States, Else Nutrition serves health-conscious parents, families with dietary restrictions, picky eaters, and plant-based lifestyles through online sales and national retailers. In November 2025, the company entered a convertible security funding agreement with Lind Global Fund III LP, managed by The Lind Partners, LLC, for gross proceeds of up to $1.28 million to support growth initiatives; earlier in 2025, it implemented a 1-for-10 share consolidation effective November 6 and reported significant operational improvements in Q3 including gross margin expansion to 34%, operating expenses down 68% year-over-year, and advancements toward U.S. regulatory milestones for plant-based infant formula via clinical trials amid favorable FDA funding and policy shifts.
Else Nutrition Commends Trump Administration's Expanded Commitment to Bolstering Infant Formulas Regulation in FY2027
Else Nutrition Reports Fiscal Year 2025 Financial Results and Highlights Operational Progress, Strengthened Financial Foundation, and Clear Path Toward Profitability
Else Nutrn (OTCMKTS:BABYF) vs. Medtronic (NYSE:MDT) Financial Survey
Else Nutrition Expected to Benefit from FDA Regulatory Progress on Infant Formula Protein Standards
Else Nutrition Surpasses One Million Cans Sold Since Launch
Else Nutrition Announces Results from Annual General Meeting of Shareholders
Else Nutrition Plans Canadian Market Relaunch in 2026
Else Nutrition Announces Appointment of Natie Zilberberg as Chief Financial Officer
Else Nutrition Achieves Transformative Operational and Financial Progress in 2025
ELSE NUTRITION ANNOUNCES FURTHER EXTENSION OF ANNUAL GENERAL MEETING OF SHAREHOLDERS
Else Nutrition Secures Five-Year Renewal of Israel's Largest Health Fund Tender for Baby Feeding Solutions
Else Nutrition Announces Major Breakthrough: President Trump Signs Pivotal FDA Funding Package that Includes Congressional Directive Streamlining Regulatory Pathway for Non-Dairy, Non-Soy Plant-Based Infant Formula
Else Nutrition Reports Significant Operational Turnaround in Q3 2025 with Gross Margin Expansion and Cost Reduction
Else Nutrition Reschedules 2025 Third Quarter Business Update Conference Call
Else Nutrition Schedules 2025 Third Quarter Business Update Conference Call
ELSE NUTRITION ANNOUNCES SHARE CONSOLIDATION
Else Nutrition Holdings Inc. (BABY:CA) Q2 2025 Earnings Call Transcript
Else Nutrition Reports 2025 Second Quarter Financial Results and Provides Business Update
Else Nutrition Schedules 2025 Second Quarter Business Update Conference Call
Else Nutrition Reports 2025 First Quarter Financial Results and Provides Business Update